Lantern Pharma Inc.LTRNNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+14.9%
5Y CAGR+42.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+14.9%/yr
vs +96.9%/yr prior
5Y CAGR
+42.2%/yr
Recent deceleration
Acceleration
-82.1pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.04M | -19.1% |
| 2024 | $16.13M | +35.6% |
| 2023 | $11.89M | +38.3% |
| 2022 | $8.60M | +13.6% |
| 2021 | $7.57M | +237.5% |
| 2020 | $2.24M | +135.3% |
| 2019 | $953185.00 | +66.6% |
| 2018 | $572095.00 | - |